You could substitute BrilAcidin and IPIX in this story and it would be mostly the same except for this...
“AI Therapeutics, a Guilford, Connecticut-based biopharmaceutical company formed by Yale alumnus Jonathan Rothberg, owns intellectual property rights to the drug.”
“Of all tyrannies, a tyranny sincerely exercised for the good of its victims may be the most oppressive...those who torment us for our own good will torment us without end for they do so with the approval of their own conscience.” C.S. Lewis